Clinical Trials Logo

Filter by:
NCT ID: NCT05004649 Completed - Visual Perception Clinical Trials

Studying the Effects of Natural Visual Scene Changes on Typical Adult Visual Perception

Start date: August 9, 2021
Phase: N/A
Study type: Interventional

The natural visual environment is complex and rich with different stimuli and features. The visual system must constantly extract behaviorally relevant visual information from an abundance of irrelevant information in the visual scene. To complicate matters further, the visual feature or stimulus that is most relevant at any given moment can change quickly and frequently in realistic visual environments. The mechanisms by which task-relevant information guides perceptual behavior are not fully understood. In this study, psychophysical experiments will be used to measure participants' ability to discriminate the horizontal position of a central object within a complex, natural visual scene, as well as to measure how that ability is affected by within-trial variability in the features of background objects in the scene. The goal of this study is to investigate the overarching prediction that the visual system extracts task-relevant information in a manner that reflects realistically complex visual environments in which the stimuli change quickly and frequently. Specifically, this study will test the hypothesis that task-irrelevant variability in the scene affects participants' ability to discriminate the visual feature that is relevant to the task at hand.

NCT ID: NCT05004636 Completed - Clinical trials for Post-operative Pain, Acute

Adductor Canal Blocks With Bupivacaine and Magnesium After Same-day Discharge Total Knee Arthroplasty Improve Post-operative Pain Relief and Decrease Opioid Consumption: a Prospective Randomized Controlled Trial

Start date: August 5, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether the addition of magnesium to bupivacaine for the post-operative adductor canal blocks (ACB) can decrease opioid consumption and improve pain management for patients after same-day discharge total knee arthroplasty (TKA). The investigators will assess whether the addition of magnesium will decrease visual analog scale (VAS) pain scores, decrease post-operative total opioid consumption (oral morphine equivalents), decrease the incidence of post-operative nausea and vomiting (PONV), and improve patient satisfaction in comparison to when magnesium is not administered.

NCT ID: NCT05004571 Completed - Safety Issues Clinical Trials

Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy Volunteers

Start date: July 6, 2021
Phase: Phase 1
Study type: Interventional

This is a randomized, placebo-controlled, double-blinded single and multiple ascending dose (SAD and MAD) study of the safety, tolerability, and pharmacokinetics of EQU-001 in healthy volunteers.

NCT ID: NCT05004454 Completed - Clinical trials for Cardiovascular Health

Effect of Bacillus Subtilis BS50 Supplementation on Gastrointestinal Symptoms in Healthy Adults

Start date: July 19, 2021
Phase: N/A
Study type: Interventional

The primary objective of this study is to investigate the effect of a novel Bacillus subtilis spore preparation on abdominal bloating, flatulence, and burping in healthy adults.

NCT ID: NCT05004415 Completed - Clinical trials for Healthy Volunteer Study

Mass Balance Study of AT-527 in Healthy Adult Male Subjects (R07496998)

Start date: July 28, 2021
Phase: Phase 1
Study type: Interventional

Mass balance study of AT-527 in Healthy Male Subjects.

NCT ID: NCT05004376 Completed - Colorectal Cancer Clinical Trials

Text-based Colorectal Cancer Prevention Pilot

Start date: January 3, 2022
Phase: N/A
Study type: Interventional

In this project, we intend to conduct a randomized pilot trial of a structured behavioral intervention, grounded in the Theory of Planned Behavior and Self-Determination Theory, to promote adherence of patients aged 45 - 75 to USPSTF colorectal cancer screening recommendations. We will also collect qualitative feedback on perceptions of the intervention to inform its refinement.

NCT ID: NCT05004337 Completed - Trisomy 21 Clinical Trials

Verification of Risk Assignment for Whole Chromosome Using SNP-based NIPT in Vanishing Twin Pregnancies

VANISH
Start date: July 22, 2021
Phase:
Study type: Observational

The purpose of this study is to collect blood samples from women carrying a vanishing twin pregnancy to further develop Natera's non-invasive prenatal screening test to provide information about possible chromosomal conditions for the living twin

NCT ID: NCT05004194 Completed - Fibromyalgia Clinical Trials

Vestibular Caloric Stimulation and the Modulation of Pain in Fibromyalgia

Start date: March 19, 2021
Phase: N/A
Study type: Interventional

The management of chronic pains is challenging and fraught with limitations. Fibromyalgia is a common pain disorder characterized by chronic widespread pains, associated with fatigue and impaired quality of life. Fibromyalgia affects millions of people and is among the most common reasons for consulting with a rheumatologist. The food and drug administration (FDA) approved three medications to treat fibromyalgia, though there are many patients for whom these medications are ineffective, poorly tolerated or cost-prohibitive. Accordingly, there exists a need for novel therapeutics. The researchers would like to test the therapeutic efficacy of a non-pharmacologic non-interventional bedside technique called vestibular caloric stimulation (VCS). VCS, irrigating the external ear canal with water, is a simple, non-invasive, cost-free procedure with preliminary data suggesting potential for improving pain. VCS is a form of neuromodulation and there are anatomically defined pathways elucidated to help explain how this works. There currently exists limited data on the topic, only case reports and case series. Given a clear need for additional therapeutics in many patients with fibromyalgia, the researchers have elected to conduct this trial.

NCT ID: NCT05004181 Completed - COVID-19 Clinical Trials

Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participants

Start date: August 25, 2021
Phase: Phase 2
Study type: Interventional

This trial consists of three parts, Part A, Part B, and Part C, and will evaluate the safety and immunogenicity of a third booster injection of the multivalent vaccine BNT162b2 (B.1.1.7 + B.1.617.2), and the safety and immunogenicity of a third booster injection of the monovalent vaccine BNT162b2 (B.1.617.2) or BNT162b2 (B.1.1.7), in participants who have received two doses of the parent vaccine BNT162b2 at 30 µg, at least 6 months after the second dose of BNT162b2. It will also evaluate the safety and immunogenicity of a three-dose regimen of BNT162b2 (B.1.1.7 + B.1.617.2) in participants who have not received prior Coronavirus Disease 2019 (COVID-19) vaccination. In addition, the safety and immunogenicity of BNT162b2 (B.1.1.529.1) or BNT162b2 given as a third or fourth vaccine dose to RNA COVID-19 vaccine-experienced participants with history of SARS-CoV-2 infection will be evaluated and contrasted with the natural immune response reached after infection with the SARS-CoV-2 Omicron variant.

NCT ID: NCT05003882 Completed - Pain Clinical Trials

Radicle ACES: A Study of Commercially Available CBD Used in the Real-world Setting

RWE-ACES
Start date: August 2, 2021
Phase:
Study type: Observational

A randomized, open-label study of commercially available, orally ingestible, Cannabidiol (CBD) products used in the real-world setting for pain, sleep, and anxiety.